GFAP and Alzheimer disease: Headway has been made in AD, where Aβ42, Aβ40, Tau-181, Tau-217 and Tau-231 are all showing promise, along with the inflammatory marker glial fibrillary acidic protein (GFAP) and neurodegenerative marker neurofilament light chain (NfL) [101].